Skip to main content
Top
Published in: Molecular Imaging and Biology 6/2018

01-12-2018 | Research Article

Optimization of a Labeling and Kit Preparation Method for Ga-68 Labeled DOTATATE, Using Cation Exchange Resin Purified Ga-68 Eluates Obtained from a Tin Dioxide 68Ge/68Ga Generator

Authors: Deidré Prince, Daniel Rossouw, Sietske Rubow

Published in: Molecular Imaging and Biology | Issue 6/2018

Login to get access

Abstract

Purpose

The aim of this study was to optimize a radiolabeling method using cationic processed Ga-68 eluates from a SnO2-based 68Ge/68Ga generator, followed by the development of DOTA-Tyr3-Thre8-octreotide (DOTATATE) kits.

Procedures

Diluted generator eluates were adsorbed on a SCX resin and desorbed with acidified 5 M NaCl solution. Optimized labeling conditions were determined by variation of pH, using 35 μg DOTATATE and sodium acetate buffer. DOTATATE kits were developed based on optimized radiolabeling conditions, were labeled, and evaluated.

Results

Optimized labeling conditions resulted in a radiolabeling efficiency of around 99 % and radiochemical yield of almost 85 %. Different kit preparation methods did not significantly influence the radiolabeling results. Kits were found to be stable over 3 months.

Conclusion

A labeling method using SCX-processed Ga-68 eluates was optimized. DOTATATE kits specifically for these SCX-processed Ga-68 eluates were successfully formulated. A post-labeling Sep-Pak C18 purification should be optional.
Literature
1.
go back to reference Fani M, André JP, Maecke HR (2008) 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging 3:67–77CrossRef Fani M, André JP, Maecke HR (2008) 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging 3:67–77CrossRef
2.
go back to reference Maecke HR, Hofmann M, Haberkorn U (2005) 68Ga-labeled peptides in tumor imaging. J Nucl Med 46:172S–178SPubMed Maecke HR, Hofmann M, Haberkorn U (2005) 68Ga-labeled peptides in tumor imaging. J Nucl Med 46:172S–178SPubMed
3.
go back to reference Breeman WAP, Verbruggen AM (2007) The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imaging 34:978–981CrossRef Breeman WAP, Verbruggen AM (2007) The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imaging 34:978–981CrossRef
4.
go back to reference Roesch F (2012) Maturation of a key resource—the germanium-68/gallium-68 generator: development and new insights. Curr Radiopharm 5:202–211CrossRef Roesch F (2012) Maturation of a key resource—the germanium-68/gallium-68 generator: development and new insights. Curr Radiopharm 5:202–211CrossRef
5.
go back to reference Breeman WAP, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP (2005) Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imaging 32:478–485CrossRef Breeman WAP, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP (2005) Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imaging 32:478–485CrossRef
6.
go back to reference de Blois E, Sze Chan H, Naidoo C, Prince D, Krenning EP, Breeman WAP (2011) Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides. Appl Radiat Isot 69:308–315CrossRef de Blois E, Sze Chan H, Naidoo C, Prince D, Krenning EP, Breeman WAP (2011) Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides. Appl Radiat Isot 69:308–315CrossRef
7.
go back to reference Rossouw DD, Breeman WAP (2012) Scaled-up radiolabelling of DOTATATE with 68Ga eluted from a SnO2-based 68Ge/68Ga generator. Appl Radiat Isot 70:171–175CrossRef Rossouw DD, Breeman WAP (2012) Scaled-up radiolabelling of DOTATATE with 68Ga eluted from a SnO2-based 68Ge/68Ga generator. Appl Radiat Isot 70:171–175CrossRef
8.
go back to reference Roesch F, Zhernosekov K, Filosofov D et al (2006) Processing of Ge-68/Ga-68 generator eluates for labeling of biomolecules via bifunctional chelators. J Nucl Med 47:162P Roesch F, Zhernosekov K, Filosofov D et al (2006) Processing of Ge-68/Ga-68 generator eluates for labeling of biomolecules via bifunctional chelators. J Nucl Med 47:162P
9.
go back to reference Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rosch F (2007) Processing of generator-produced 68Ga for medical application. J Nucl Med 48:1741–1748CrossRef Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rosch F (2007) Processing of generator-produced 68Ga for medical application. J Nucl Med 48:1741–1748CrossRef
10.
go back to reference Asti M, De Pietri G, Fraternali A et al (2008) Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC. Nucl Med Biol 35:721–724CrossRef Asti M, De Pietri G, Fraternali A et al (2008) Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC. Nucl Med Biol 35:721–724CrossRef
11.
go back to reference Ocak M, Antretter M, Knopp R, Kunkel F, Petrik M, Bergisadi N, Decristoforo C (2010) Full automation of 68Ga labelling of DOTA-peptides including cation exchange prepurification. Appl Radiat Isot 68:297–302CrossRef Ocak M, Antretter M, Knopp R, Kunkel F, Petrik M, Bergisadi N, Decristoforo C (2010) Full automation of 68Ga labelling of DOTA-peptides including cation exchange prepurification. Appl Radiat Isot 68:297–302CrossRef
12.
go back to reference Mueller D, Klette I, Baum RP, Gottschaldt M, Schultz MK, Breeman WAP (2012) Simplified NaCl based 68Ga concentration and labeling procedure for rapid synthesis of 68Ga radiopharmaceuticals in high radiochemical purity. Bioconjug Chem 23:1712–1717CrossRef Mueller D, Klette I, Baum RP, Gottschaldt M, Schultz MK, Breeman WAP (2012) Simplified NaCl based 68Ga concentration and labeling procedure for rapid synthesis of 68Ga radiopharmaceuticals in high radiochemical purity. Bioconjug Chem 23:1712–1717CrossRef
13.
go back to reference Schultz MK, Mueller D, Baum RP, Leonard Watkins G, Breeman WAP (2013) A new automated NaCl based robust method for routine production of gallium-68 labeled peptides. Appl Radiat Isot 76:46–54CrossRef Schultz MK, Mueller D, Baum RP, Leonard Watkins G, Breeman WAP (2013) A new automated NaCl based robust method for routine production of gallium-68 labeled peptides. Appl Radiat Isot 76:46–54CrossRef
14.
go back to reference Martin R, Jüttler S, Müller M, Wester HJ (2014) Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2. Nucl Med Biol 41:84–89CrossRef Martin R, Jüttler S, Müller M, Wester HJ (2014) Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2. Nucl Med Biol 41:84–89CrossRef
15.
go back to reference Seemann J, Eppard E, Waldron BP, Ross TL, Roesch F (2015) Cation exchange-based post-processing of 68Ga eluate: a comparison of three solvent systems for labelling of DOTATOC, NO2APBP and DATAm. Appl Radiat Isot 98:54–59CrossRef Seemann J, Eppard E, Waldron BP, Ross TL, Roesch F (2015) Cation exchange-based post-processing of 68Ga eluate: a comparison of three solvent systems for labelling of DOTATOC, NO2APBP and DATAm. Appl Radiat Isot 98:54–59CrossRef
16.
go back to reference Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A (2014) Development of single vial kits for preparation of 68Ga-labelled peptides for PET imaging of neuroendocrine tumours. Mol Imaging Biol 16:550–557CrossRef Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A (2014) Development of single vial kits for preparation of 68Ga-labelled peptides for PET imaging of neuroendocrine tumours. Mol Imaging Biol 16:550–557CrossRef
17.
go back to reference Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A (2014) Single vial kit formulation for preparation of PET radiopharmaceutical: 68Ga-DOTA-TOC. J Radioanal Nucl Chem 302:1253–1258CrossRef Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A (2014) Single vial kit formulation for preparation of PET radiopharmaceutical: 68Ga-DOTA-TOC. J Radioanal Nucl Chem 302:1253–1258CrossRef
18.
go back to reference Das T, Bhadwal M, Sarma HD, Banerjee S (2014) Formulation and radiochemical evaluation of a freeze-dried mixed peptide kit for the preparation of 68Ga-labeled peptides for PET imaging of somatostatin receptor positive neuroendocrine cancers. J Radioanal Nucl Chem 302:1259–1264CrossRef Das T, Bhadwal M, Sarma HD, Banerjee S (2014) Formulation and radiochemical evaluation of a freeze-dried mixed peptide kit for the preparation of 68Ga-labeled peptides for PET imaging of somatostatin receptor positive neuroendocrine cancers. J Radioanal Nucl Chem 302:1259–1264CrossRef
19.
go back to reference Asti M, Iori M, Capponi PC, Rubagotti S, Fraternali A, Versari A (2015) Development of a simple kit-based method for preparation of pharmaceutical-grade 68Ga-DOTATOC. Nucl Med Commun 36(5):502–510PubMed Asti M, Iori M, Capponi PC, Rubagotti S, Fraternali A, Versari A (2015) Development of a simple kit-based method for preparation of pharmaceutical-grade 68Ga-DOTATOC. Nucl Med Commun 36(5):502–510PubMed
20.
go back to reference Mukherjee A, Korde A, Sarma HD, Samuel G (2014) Single vial formulation for theranostic radiopharmaceutical preparation. J Radioanal Nucl Chem 302:889–894CrossRef Mukherjee A, Korde A, Sarma HD, Samuel G (2014) Single vial formulation for theranostic radiopharmaceutical preparation. J Radioanal Nucl Chem 302:889–894CrossRef
21.
go back to reference Prince D, Rossouw D, Davids C, Rubow S (2017) Development and evaluation of user-friendly single vial DOTA-peptide kit formulations, specifically designed for radiolabelling with 68Ga from a tin dioxide 68Ge/68Ga generator. Mol Imaging Biol 19:817–824CrossRef Prince D, Rossouw D, Davids C, Rubow S (2017) Development and evaluation of user-friendly single vial DOTA-peptide kit formulations, specifically designed for radiolabelling with 68Ga from a tin dioxide 68Ge/68Ga generator. Mol Imaging Biol 19:817–824CrossRef
22.
go back to reference Hofmann M, Maecke H, Börner AR, Weckesser E, Schöffski P, Oei M, Schumacher J, Henze M, Heppeler A, Meyer G, Knapp W (2001) Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 28:1751–1757CrossRef Hofmann M, Maecke H, Börner AR, Weckesser E, Schöffski P, Oei M, Schumacher J, Henze M, Heppeler A, Meyer G, Knapp W (2001) Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 28:1751–1757CrossRef
23.
go back to reference Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, Mäcke HR, Hofmann M, Debus J, Haberkorn U (2001) PET imaging of somatostatin receptors using [68Ga]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med 42:1053–1056PubMed Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, Mäcke HR, Hofmann M, Debus J, Haberkorn U (2001) PET imaging of somatostatin receptors using [68Ga]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas. J Nucl Med 42:1053–1056PubMed
24.
go back to reference Decristoforo C, Knopp R, von Guggenberg E, Rupprich M, Dreger T, Hess A, Virgolini I, Haubner R (2007) A fully automated synthesis for the preparation of 68Ga-labelled peptides. Nucl Med Commun 28:870–875CrossRef Decristoforo C, Knopp R, von Guggenberg E, Rupprich M, Dreger T, Hess A, Virgolini I, Haubner R (2007) A fully automated synthesis for the preparation of 68Ga-labelled peptides. Nucl Med Commun 28:870–875CrossRef
25.
go back to reference Velikyan I, Beyer GJ, Långström B (2004) Microwave-supported preparation of 68Ga bioconjugates with high specific radioactivity. Bioconjug Chem 15:554–560CrossRef Velikyan I, Beyer GJ, Långström B (2004) Microwave-supported preparation of 68Ga bioconjugates with high specific radioactivity. Bioconjug Chem 15:554–560CrossRef
26.
go back to reference Velikyan I, Sundin A, Eriksson B, Lundqvist H, Sörensen J, Bergström M, Långström B (2010) In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours—impact of peptide mass. Nucl Med Biol 37:265–275CrossRef Velikyan I, Sundin A, Eriksson B, Lundqvist H, Sörensen J, Bergström M, Långström B (2010) In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours—impact of peptide mass. Nucl Med Biol 37:265–275CrossRef
27.
go back to reference Velikyan I, Xu H, Nair M, Hall H (2012) Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE. Nucl Med Biol 39:628–639CrossRef Velikyan I, Xu H, Nair M, Hall H (2012) Robust labeling and comparative preclinical characterization of DOTA-TOC and DOTA-TATE. Nucl Med Biol 39:628–639CrossRef
28.
go back to reference Meyer GJ, Hofmann M, Kühn J et al (2003) 68Ga-labelled DOTA-derivatised peptide ligands. J Labelled Comp Radiopharm 46:S273CrossRef Meyer GJ, Hofmann M, Kühn J et al (2003) 68Ga-labelled DOTA-derivatised peptide ligands. J Labelled Comp Radiopharm 46:S273CrossRef
Metadata
Title
Optimization of a Labeling and Kit Preparation Method for Ga-68 Labeled DOTATATE, Using Cation Exchange Resin Purified Ga-68 Eluates Obtained from a Tin Dioxide 68Ge/68Ga Generator
Authors
Deidré Prince
Daniel Rossouw
Sietske Rubow
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Molecular Imaging and Biology / Issue 6/2018
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-018-1195-x

Other articles of this Issue 6/2018

Molecular Imaging and Biology 6/2018 Go to the issue